High levels of IL-6 and chemokine (C-C motif) ligand 2 (CCL2) in MDS patients may additionally induce MDCSs, as these molecules activate the STAΤ3 pathway, which is crucial for MDSC-mediated inhibition of CD8+ T cell function [178]. Here, CCL2 is linked to myelodysplastic syndrome.